118 related articles for article (PubMed ID: 5708420)
1. [Chemotherapy of malignant lymphoma].
Wakisaka G; Nakamura T; Shirakawa S; Tanabe Y; Sawada H
Naika; 1968 Aug; 22(2):440-7. PubMed ID: 5708420
[No Abstract] [Full Text] [Related]
2. The effects of leukemia and lymphoma chemotherapy on hematopoietic cells.
Brunning RD
Am J Med Technol; 1973 May; 39(5):165-74. PubMed ID: 4701364
[No Abstract] [Full Text] [Related]
3. [Chemotherapy of bladder cancer].
Cappelaere P
Acta Urol Belg; 1971 Jan; 39(1):18-23. PubMed ID: 4996465
[No Abstract] [Full Text] [Related]
4. Chemotherapy of breast cancer.
Hall TC
Clin Obstet Gynecol; 1968 Jun; 11(2):401-15. PubMed ID: 4972174
[No Abstract] [Full Text] [Related]
5. [Drug therapy of cervical cancer].
Dekster LI
Vopr Onkol; 1974; 20(8):94-102. PubMed ID: 4215223
[No Abstract] [Full Text] [Related]
6. Place of chemotherapy in the management of malignant diseases. A retrospective study of 86 cases.
Gupta BD; Hingorani V; Dhawan IK; Abrol BM
Indian J Cancer; 1974 Mar; 11(1):54-9. PubMed ID: 4137882
[No Abstract] [Full Text] [Related]
7. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
8. Cancer chemotherapy.
Walton MR
Br J Clin Pract; 1972 Apr; 26(4):159-63. PubMed ID: 5036483
[No Abstract] [Full Text] [Related]
9. [Mechanism of action of immunosuppressive drugs].
Dimitriu CG; Zeana C
Med Interna (Bucur); 1972 Aug; 24(8):977-83. PubMed ID: 5080894
[No Abstract] [Full Text] [Related]
10. [Antineoplastic chemotherapy in gynecology; some generalizations].
Wolff JP
Gynecol Prat; 1967; 18(6):525-30. PubMed ID: 4987387
[No Abstract] [Full Text] [Related]
11. [Immunosuppressive agents in therapy].
Ann Med Nav (Roma); 1968; 73(5):447-51. PubMed ID: 5743220
[No Abstract] [Full Text] [Related]
12. Immunosuppression and immunomodulation.
Goust JM; Stevenson H; Galbraith R; Virella G
Immunol Ser; 1993; 58():465-80. PubMed ID: 8424989
[No Abstract] [Full Text] [Related]
13. The present approach to systematic cancer therapy.
Mukerjea DN; Koven BJ
Indian J Cancer; 1970 Sep; 7(3):174-90. PubMed ID: 4927710
[No Abstract] [Full Text] [Related]
14. The need for additional alkylating agents and antimetabolites.
Heidelberger C
Cancer Res; 1969 Dec; 29(12):2435-42. PubMed ID: 4905240
[No Abstract] [Full Text] [Related]
15. Chemotherapy in the treatment of head and neck cancer.
Daly JF
Minn Med; 1967 Jun; 50(6):1016-9. PubMed ID: 6041495
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of cancer].
Saito T
Gan No Rinsho; 1968 Jan; 14(1):71-3. PubMed ID: 5692170
[No Abstract] [Full Text] [Related]
17. Chemotherapy. Changing concepts in therapy.
Wright JC
Minn Med; 1970 Apr; 53(4):373-7. PubMed ID: 5467605
[No Abstract] [Full Text] [Related]
18. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
Lin PT; Martin BA; Weinacker AB; So YT
Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor chemotherapy. Trial and results of a new antineoplastic agent with a double mechanism of alkylating and antimetabolic action].
Battaglia L
Clin Ter; 1974 Dec; 71(6):573-93. PubMed ID: 4448054
[No Abstract] [Full Text] [Related]
20. [Alkylating agents and antimetabolites in nephrotic syndromes of the infant].
Lagrue G; Bariéty J
Cah Coll Med Hop Paris; 1967 Sep; 8(10):903-12. PubMed ID: 5619507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
